Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer

OBJECTIVE. The ideal number of neoadjuvant chemotherapy (NACT) cycles prior to interval tumor-reductive surgery (iTRS) for advanced ovarian cancer is poorly defined. We sought to assess survival stratified by number of NACT cycles and residual disease following iTRS in patients with advanced ovarian...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecol Oncol
Hauptverfasser: Nitecki, Roni, Fleming, Nicole D., Fellman, Bryan M., Meyer, Larissa A., Sood, Anil K., Lu, Karen H., Rauh-Hain, J. Alejandro
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165031/
https://ncbi.nlm.nih.gov/pubmed/33867146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2021.04.012
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge